VC firm
Adjuvant Capital
- Investor type
- VC
- Investing status
- Activeas of 2026-09-17Source (opens in a new tab)
- Headquarters
- New York, NY, United States
- Assets under management
- $300MStated by firm, as of 2026-09-17Source (opens in a new tab)
- Funds
- 2
- Legal name
- Adjuvant Capital Management, LLC
Record updated 30 September 2026
About
Adjuvant is a new type of venture capital firm. We finance the most promising life science technologies for high-burden public health challenges. We see enormous opportunity in historically overlooked market segments, and we leverage our unique expertise to translate these opportunities into social and financial returns for our investors.
Investment approach
- Thesis
- Our mission is simple: use venture capital strategies to deploy capital in the most promising public health technologies and ensure they are made accessible to those who need them most.Source (opens in a new tab)
- Eligibility
- Adjuvant directs the majority of its investment activity to opportunities that have human efficacy signals from a phase II-or-later clinical trial or similar arm’s-length evaluations.
- Traction requirement
- Adjuvant directs the majority of its investment activity to opportunities that have human efficacy signals from a phase II-or-later clinical trial or similar arm’s-length evaluations. We look for compelling proof-of-concept data to support our investment decisions.
- Investing status notes
- We invest in innovative technologies to address high-burden and neglected infectious diseases, maternal and child health, nutrition, and reproductive and sexual health.
Funds
- ADJUVANT GLOBAL HEALTH TECHNOLOGY FUND, L.P.
- Main fund
- ADJUVANT GLOBAL HEALTH TECHNOLOGY FUND DE, L.P.
- Main fund
SEC registration
- Registered adviser
- ADJUVANT CAPITAL, LP
- CRD number
- 301716 (opens in a new tab)
- SEC file number
- 802-129182
- Registration
- Exempt reporting adviser
- Regulatory AUM
- $170Mas of 2026-03-27
- Private funds reported
- 2
- Principal office
- NEW YORK, NY, United States
Locations
- Office
- Schlieren, Switzerland
- Office
- New York, NY, United States